Education
About Us
Working with TipRanks
Follow Us
Hansa Biopharma (SE:HNSA)
:HNSA
HNSA Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HNSA Stock 12 Month Forecast
Average Price Target
kr143.00
▲(535.56% Upside)
| Highest Price Targetkr143.00 | Average Price Targetkr143.00 | Lowest Price Targetkr143.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
02/07/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
02/07/25
HNSA Analyst Recommendation Trends
Rating
Jul 24
Sep 24
Oct 24
Dec 24
Feb 25
Strong Buy
4
3
4
4
4
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
3
4
4
4
Each month's total comprises the sum of three months' worth of ratings.
HNSA Financial Forecast
HNSA Stock Forecast FAQ
What is SE:HNSA’s average 12-month price target, according to analysts?
Based on analyst ratings, Hansa Biopharma’s 12-month average price target is kr143.00.
What is SE:HNSA’s upside potential, based on the analysts’ average price target?
Hansa Biopharma has 535.56% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Hansa Biopharma a Buy, Sell or Hold?
Hansa Biopharma has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Hansa Biopharma’s share price target?
The average share price target for Hansa Biopharma is kr143.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr143.00 ,and the lowest forecast is kr143.00. The average share price target represents 535.56% Increase from the current price of kr22.5.
The highest analyst share price target is kr143.00 ,and the lowest forecast is kr143.00. The average share price target represents 535.56% Increase from the current price of kr22.5.
What do analysts say about Hansa Biopharma?
Hansa Biopharma’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Hansa Biopharma?
To buy shares of SE:HNSA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.